170 related articles for article (PubMed ID: 6492992)
1. Differential effects of chronic clorgyline and amfonelic acid on desensitization of striatal dopamine receptors.
Meller E; Bohmaker K; Friedhoff AJ
Life Sci; 1984 Oct; 35(18):1829-38. PubMed ID: 6492992
[TBL] [Abstract][Full Text] [Related]
2. Chronic clorgyline and pargyline increase apomorphine-induced stereotypy in the rat.
Campbell IC; Durcan MJ; Cohen RM; Pickar D; Chugani D; Murphy DL
Pharmacol Biochem Behav; 1985 Dec; 23(6):921-5. PubMed ID: 4080777
[TBL] [Abstract][Full Text] [Related]
3. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Jenner P; Rupniak NM; Marsden CD
Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
[TBL] [Abstract][Full Text] [Related]
4. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
6. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
7. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats.
Gulati A; Srimal RC; Dhawan BN
Pharmacology; 1988; 36(6):396-404. PubMed ID: 2901759
[TBL] [Abstract][Full Text] [Related]
8. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Globus M; Bannet J; Lerer B; Belmaker RH
Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
[TBL] [Abstract][Full Text] [Related]
9. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
[TBL] [Abstract][Full Text] [Related]
10. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
11. Chronic rubidium does not prevent dopamine receptor supersensitivity.
Bannet J; Ebstein RP; Hershkowitz M; Belmaker RH
Neuropsychobiology; 1982; 8(6):281-3. PubMed ID: 6298653
[No Abstract] [Full Text] [Related]
12. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF; Thal L; Gardner EL
Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
[TBL] [Abstract][Full Text] [Related]
13. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
Meller E
Psychopharmacology (Berl); 1982; 76(3):222-7. PubMed ID: 6808540
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
[TBL] [Abstract][Full Text] [Related]
15. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
DeLucia R; Scavone C; Camillo MA
Braz J Med Biol Res; 1989; 22(6):741-3. PubMed ID: 2620186
[TBL] [Abstract][Full Text] [Related]
16. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
[TBL] [Abstract][Full Text] [Related]
17. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
Chivers JK; Reavill C; Jenner P; Marsden CD
J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
Paetsch PR; Greenshaw AJ
Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
[TBL] [Abstract][Full Text] [Related]
19. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
Pittman KJ; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
[TBL] [Abstract][Full Text] [Related]
20. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
